Initial evaluation of (4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

PURPOSE: (4S)-4-(3-[(18)F]Fluoropropyl)-l-glutamic acid ([(18)F]FSPG) measures system x(C)(−) transporter activity and shows promise for oncologic imaging. We present data on tumor uptake of this radiopharmaceutical in human subjects with head and neck cancer (HNC), colorectal cancer (CRC), and non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sonya Y., Mosci, Camila, Kumar, Meena, Wardak, Mirwais, Koglin, Norman, Bullich, Santiago, Mueller, Andre, Berndt, Mathias, Stephens, Andrew W., Chin, Frederick T., Gambhir, Sanjiv S., Mittra, Erik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455665/
https://www.ncbi.nlm.nih.gov/pubmed/32857284
http://dx.doi.org/10.1186/s13550-020-00678-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455665/
https://www.ncbi.nlm.nih.gov/pubmed/32857284
http://dx.doi.org/10.1186/s13550-020-00678-2

Ejemplares similares